Evolent Health (EVH) Enterprise Value (2015 - 2026)

Evolent Health's Enterprise Value history runs 12 years deep, the most recent figure standing at -$166.0 million for Q1 2026.

• In Q1 2026, Enterprise Value rose 36.84% year-over-year to -$166.0 million; the TTM figure through Mar 2026 stood at -$166.0 million (up 36.84% YoY), while the FY2025 annual figure was -$178.0 million, down 8.86% from the prior year.
• Enterprise Value was -$166.0 million for Q1 2026 at Evolent Health, up from -$178.0 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$112.9 million in Q3 2024 to a low of -$267.4 million in Q2 2022.
• Historically, Enterprise Value has averaged -$189.6 million across 5 years, with a median of -$181.8 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value jumped 45.64% in 2024, then slumped 44.57% in 2025.
• A 5-year view of Enterprise Value shows it stood at -$202.7 million in 2022, then declined by 1.92% to -$206.6 million in 2023, then gained by 20.86% to -$163.5 million in 2024, then dropped by 8.86% to -$178.0 million in 2025, then climbed by 6.75% to -$166.0 million in 2026.
• The last three Enterprise Value figures came in at -$166.0 million (Q1 2026), -$178.0 million (Q4 2025), and -$140.3 million (Q3 2025), per Business Quant data.